NLSP
Company News
NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-Selection and Enrichment Technology for IsletRx for Diabetes Patients
NLS Pharmaceutics and Kadimastem have been granted a Hong Kong patent for cell-selection technology used in IsletRx, a stem cell-derived therapy for insulin-dependent diabetes, expanding their intellectual property protection in Asia.
Investing in Penny Stocks With $1k, What to Know
Read this before investing in penny stocks The post Investing in Penny Stocks With $1k, What to Know appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
